Hostname: page-component-cd9895bd7-dzt6s Total loading time: 0 Render date: 2024-12-26T05:50:05.991Z Has data issue: false hasContentIssue false
  • English
  • Français

Altered endothelial function following the Fontan procedure

Published online by Cambridge University Press:  20 December 2007

Maria A. Binotto ,
Nair Y. Maeda  and
Antonio A. Lopes
Maria A. Binotto*
Affiliation:
Department of Paediatric Cardiology and Adult Congenital Heart Disease, Heart Institute (InCor)
Nair Y. Maeda
Affiliation:
Pró-Sangue Foundation, Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo, Brazil
Antonio A. Lopes
Affiliation:
Department of Paediatric Cardiology and Adult Congenital Heart Disease, Heart Institute (InCor)
*
Correspondence to: Dr Maria Angelica Binotto, Av Dr Eneas Carvalho de Aguiar, 44, 05403-000, São Paulo, Brazil. Tel/Fax: +55 11 30695409; E-mail: angelica.binotto@incor.usp.br
Get access Rights & Permissions [Opens in a new window]

Abstract

Objective

Thrombosis has been widely described after the Fontan procedure. The vascular endothelium plays a central role in the control of coagulation and fibrinolysis. The aim of this study was to investigate if patients undergoing a modified Fontan procedure have impaired endothelial function and fibrinolysis in the late postoperative course.

Patients and methods

We compared 23 patients aged from 7 to 26 years with age-matched healthy volunteers, collecting blood samples prior to and following standardized venous occlusion testing. Plasma levels of von Willebrand factor antigen, tissue-type plasminogen activator antigen, plasminogen activator inhibitor-1, and D-dimer were measured with enzyme-linked immunosorbent assay.

Results

We found increased plasma levels of von Willebrand factor antigen in patients when compared to controls (p = 0.003). At the basal condition, concentrations of tissue-type plasminogen activator antigen and plasminogen activator inhibitor-1 antigen in the plasma, as well as their activity, were not significantly different between patients and controls. Following venous occlusion, concentrations of tissue-type plasminogen activator antigen in the plasma were significantly increased both in patients and controls, compared to pre-occlusion values. D-dimer was within the reference range. Multivariate discriminant analysis differentiated patients and their controls on the basis of differences for plasminogen activator inhibitor-1 and von Willebrand factor antigen (p = 0.0016).

Conclusions

Our data suggest that patients with the Fontan circulation may have endothelial dysfunction, as indicated by raised levels of von Willebrand factor. Fibrinolysis seems to be relatively preserved, as suggested by appropriate response to venous occlusion.

Keywords

Functionally univentricular heartfibrinolysisthrombosis
Type
Original Article
Information
Cardiology in the Young , Volume 18 , Issue 1 , February 2008 , pp. 70 - 74
Copyright
Copyright © Cambridge University Press 2008

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

1. Day, RW, Boyer, RS, Tait, VF, Ruttenberg, HD. Factors associated with stroke following the Fontan procedure. Pediatr Cardiol 1995; 16: 270–275.CrossRefGoogle ScholarPubMed
2. du Plessis, AJ, Chang, AC, Wessel, DL, et al. . Cerebrovascular accidents following the Fontan operation. Pediatr Neurol 1995; 12: 230–236.Google Scholar
3. Jahangiri, M, Shore, D, Kakkar, V, Lincoln, C, Shinebourne, E. Coagulation factor abnormalities after the Fontan procedure and its modifications. J Thorac Cardiovasc Surg 1997; 113: 989–992.CrossRefGoogle ScholarPubMed
4. Rosenthal, DN, Friedman, AH, Kleinman, CS, Kopf, GS, Rosenfeld, LE, Hellenbrand, WE. Thromboembolic complications after Fontan operations. Circulation 1995; 92: II287–II293.CrossRefGoogle ScholarPubMed
5. Cromme-Dijkhuis, AH, Henkens, CM, Bijleveld, CM, Hillege, HL, Bom, VJ, van der Meer, J. Coagulation factor abnormalities as possible thrombotic risk factors after Fontan operations. Lancet 1990; 336: 1087–1090.CrossRefGoogle ScholarPubMed
6. Jahangiri, M, Kreutzer, J, Zurakowski, D, Bacha, E, Jonas, RA. Evaluation of hemostatic and coagulation factor abnormalities in patients undergoing the Fontan operation. J Thorac Cardiovasc Surg 2000; 120: 778–782.CrossRefGoogle ScholarPubMed
7. Odegard, KC, McGowan, FX Jr, DiNardo, JA, et al. . Coagulation abnormalities in patients with single-ventricle physiology precede the Fontan procedure. J Thorac Cardiovasc Surg 2002; 123: 459–465.CrossRefGoogle ScholarPubMed
8. Odegard, KC, McGowan, FX Jr, Zurakowski, D, et al. . Coagulation factor abnormalities in patients with single-ventricle physiology immediately prior to the Fontan procedure. Ann Thorac Surg 2002; 73: 1770–1777.Google Scholar
9. Rauch, R, Ries, M, Hofbeck, M, Buheitel, G, Singer, H, Klinge, J. Hemostatic changes following the modified Fontan operation (total cavopulmonary connection). Thromb Haemost 2000; 83: 678–682.Google ScholarPubMed
10. Ravn, HB, Hjortdal, VE, Stenbog, EV, et al. . Increased platelet reactivity and significant changes in coagulation markers after cavopulmonary connection. Heart 2000; 85: 61–65.Google Scholar
11. Barac, A, Campia, U, Panza, JA. Methods for evaluating endothelial function in humans. Hypertension 2007; 49: 748–760.CrossRefGoogle ScholarPubMed
12. Inai, K, Saita, Y, Takeda, S, Nakazawa, M, Kimura, H. Skeletal muscle hemodynamics and endothelial function in patients after Fontan operation. Am J Cardiol 2004; 93: 792–797.CrossRefGoogle ScholarPubMed
13. Mahle, WT, Todd, K, Fyfe, DA. Endothelial function following the Fontan operation. Am J Cardiol 2003; 91: 1286–1288.CrossRefGoogle ScholarPubMed
14. Kempter, B, Peinemann, A, Biniasch, O, Haberl, RL. Decreased fibrinolytic stimulation by a short-term venous occlusion test in patients with cerebrovascular disease. Thromb Res 1995; 79: 363–368.CrossRefGoogle ScholarPubMed
15. Lacroix, KA, Bean, C, Box, L, Wagner, K. A study of the fibrinolytic response in healthy men and women following a brief exposure to venous occlusion. Thromb Res 1996; 81: 133–143.CrossRefGoogle ScholarPubMed
16. Mizuno, A, Isobe, J, Shima, K. Simplification of a venous occlusion test. Thromb Res 1991; 62: 83–92.CrossRefGoogle ScholarPubMed
17. Keber, D. On the use of different correction factors for hemoconcentration. Thromb Haemost 1983; 49: 245.Google ScholarPubMed
18. Oliver, JJ, Webb, DJ, Newby, DE. Stimulated tissue plasminogen activator release as a marker of endothelial function in humans. Arterioscler Thromb Vasc Biol 2005; 25: 2470–2479.CrossRefGoogle ScholarPubMed
19. Blann, AD. Plasma von Willebrand factor, thrombosis, and the endothelium: the first 30 years. Thromb Haemost 2006; 95: 49–55.Google Scholar
20. Olli, R, Celermajer, DS. Testing for endothelial dysfunction. Ann Med 2000; 32: 293–304.Google Scholar
21. Morgan, VL, Graham, TP Jr, Roselli, RJ, Lorenz, CH. Alterations in pulmonary artery flow patterns and shear stress determined with three-dimensional phase-contrast magnetic resonance imaging in Fontan patients. J Thorac Cardiovasc Surg 1998; 116: 294–304.CrossRefGoogle ScholarPubMed
22. Moyle, KR, Mallinson, GD, Occleshaw, CJ, Cowana, BR, Gentles, TL. Wall shear stress is the primary mechanism of energy loss in the Fontan connection. Pediatr Cardiol 2006; 27: 309–315.Google Scholar
23. Inai, K, Nakanishi, T, Nakazawa, M. Clinical correlation and prognostic predictive value of neurohumoral factors in patients late after the Fontan operation. Am Heart J 2005; 150: 588–594.CrossRefGoogle ScholarPubMed
24. Binotto, MA, Maeda, NY, Lopes, AA. Evidence of endothelial dysfunction in patients with functionally univentricular physiology before completion of the Fontan operation. Cardiol Young 2005; 15: 26–30.CrossRefGoogle ScholarPubMed
25. Pinsky, DJ, Naka, Y, Liao, H, et al. . Hypoxia-induced exocytosis of endothelial cell Weibel-Palade bodies. A mechanism for rapid neutrophil recruitment after cardiac preservation. J Clin Invest 1996; 97: 493–500.Google Scholar
26. Shreeniwas, R, Ogawa, S, Torcia, G, et al. . Macrovascular and microvascular endothelium during long-term hypoxia: alterations in cell growth, monolayer permeability, and cell surface coagulant properties. J Cell Physiol 1991; 146: 8–17.Google Scholar
27. Ten, VS, Pinsky, DJ. Endothelial response to hypoxia: physiologic adaptation and pathologic dysfunction. Curr Opin Crit Care 2002; 8: 242–250.Google Scholar
28. Felmeden, DC, Blann, AD, Spencer, CG, Beevers, DG, Lip, GY. A comparison of flow-mediated dilatation and von Willebrand factor as markers of endothelial cell function in health and in hypertension: relationship to cardiovascular risk and effects of treatment: a substudy of the Anglo-Scandinavian Cardiac Outcomes Trial. Blood Coagul Fibrinolysis 2003; 14: 425–431.CrossRefGoogle ScholarPubMed
29. Alessi, MC, Juhan-Vague, I, Valadier, J, Philip Joet, C, Holvoet, P, Collen, D. Relevance of free tPA assay following venous occlusion in patients with venous thromboembolic disease. Thromb Haemost 1988; 59: 346–347.Google Scholar
30. Monagle, P, Chan, AK, Albisetti, M, Vegh, P, Andrew, M, Mitchell, L. Fibrinolytic system in adolescents: response to venous occlusion stress tests. Pediatr Res 2003; 53: 333–337.CrossRefGoogle ScholarPubMed